Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LCID✓SelectedUSD · LCIDGSK vs LCID performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs LCID

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.3%
LCID return
-79.2%
Excess return
+86.5%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioLCIDExcessAlpha
1D-2.3%+3.9%-6.2%-2.5%
7D-3.0%-22.8%+19.8%-1.6%
30D+0.4%-7.0%+7.4%+0.5%
3M-1.2%-53.2%+52.0%+2.3%
6M+0.9%-51.8%+52.8%+3.4%
YTD+4.0%-72.5%+76.5%+10.3%
1Y+7.3%-77.5%+84.8%+17.1%
All+7.3%-79.2%+86.5%+17.1%

Cumulative growth

Daily Returns

Daily percentage return beside LCID.

Daily Out/Under-Performance

Portfolio return minus LCID return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LCID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded LCID wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling